Gregory Fiore

Gregory Fiore

Company: Exacis Biotherapeutics

Job title: Chief Executive Officer

Seminars:

Panel:Reviewing Methods to Editing iPSCs to Increase Therapy Persistence & Cell Retention in vivo 1:30 pm

Discussing how to increase cell survival to produce effective regenerative cell replacement therapies Assessing methods to ensure iPSC therapies for immunology persist long enough for effective tumor killing Does administration of the cell therapy affect retention in the body?Read more

day: Day 1 Track 1 AM

Boosting Genetic Engineering of iPSCs to Prevent Genetic Instability 1:00 pm

Maximizing on-target editing to ensure higher yields of stable cells Improving efficiencies of multiplex targeting to reduce genetic variation Distinguishing the optimal time to edit iPSC cells to enhance editing efficiencyRead more

day: Day 1 Track 1 AM

Industry Leaders’ Fireside Chat: Taking a Look at the Current Learnings from iPSC-Derived Cell Therapies & Determining Future Outlook & Developments 8:30 am

Reflecting on current learnings from therapy development to drive focus and motivation while highlighting demands of the future Validating iPSCs as a starting material for immuno-oncology and regenerative medicine therapies to drive further investment and efforts in the spaceRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.